SandboxAQ, an artificial intelligence startup backed by Nvidia (NASDAQ:NVDA) and born from Alphabet's (NASDAQ:GOOG, GOOGL)) Google, has released a dataset containing 5.2 million synthetic molecules aimed at transforming how scientists predict drug-protein binding, Reuters reports.
Rather than generating the data through lab experiments, SandboxAQ used Nvidia chips and scientific computing methods to create synthetic 3D molecules, using physics-based equations grounded in real-world data. According to Reuters, the goal is to significantly reduce the time associated with discovering new drugs.
